Home TMU Sitemap FAQ Links
正體中文
Home Ongoing Clinical Trials
Ongoing Clinical Trials

Institution
Principal Investigator
Protocol Title
Keyword
TMU-JIRB No. Protocol Title Institution / Principal Investigator Type of Study Phases of Clinical Trials for Drugs
N202509037 A Phase I, Open-label, Dose-finding Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of LBL-01 Injection in Patients with Advanced Solid Tumors New Medical Device NA
N202509040 G-BeBite Dental Implant System Clinical Trial Plan New Medical Device NA
N202509054 A Randomized, Double-Blind, Phase 1/2a Study to Evaluate the Safety, Tolerability, PK and PD of DB-2304 for Injection in Healthy Adult Participants and Participants with Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus New Drug Phase Ⅲ
N202509074 A Phase IIb Randomized, Double-blind, Placebo-controlled, Parallel, Multidose Study to Evaluate the Efficacy, Safety, and PK of AZD0292 in Participants 12 years of Age and Older With Bronchiectasis and Chronic Pseudomonas aeruginosa Colonization New Medical Device NA
N202509087 Microneedling for androgenic alopecia: a clinical study New Drug Phase Ⅲ
N202510003 A Phase II, double-blind, randomized, placebo-controlled, parallel-group, multiple-dose study to investigate the safety and efficacy of 3-month AD17002 treatment in adult subjects with inadequately controlled moderate to severe eosinophilic asthma New Drug Phase Ⅱ / NA
N202510009 A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of dapirolizumab pegol in study participants with moderately to severely active systemic lupus erythematosus New Drug Phase Ⅲ
N202510011 An Open-label, Multicenter, Phase 1/2 Study Exploring the Safety and Efficacy of ABT-301 in Combination with Tislelizumab and Bevacizumab in Participants with Proficient Mismatch Repair (pMMR)/non-Microsatellite Instability-High (non-MSI-H) Locally Advanced or Metastatic Colorectal Cancer (mCRC) New Drug Phase Ⅰ
N202510018 Development and Clinical Validation of AI Digital Therapeutics System for Attentional Deficits New Drug Phase Ⅰ
1 2 10 11 12 13 14 15 16 31 32 / 32

TOP